1.
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes
by Roumestand, Christian
Nature biotechnology, 2003-01, Vol.21 (1), p.71-76
2.
Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epith...
by GRANIO, Ophélia
Human gene therapy, 2010, Vol.21 (3), p.251-269
3.
Nanoparticles as vehicles for delivery of photodynamic therapy agents
by Bechet, Denise
Trends in biotechnology (Regular ed.), 2008, Vol.26 (11), p.612-621
4.
Roadmap for implementation of quality by design (QbD) for biotechnology products
by Rathore, Anurag S
Trends in biotechnology (Regular ed.), 2009, Vol.27 (9), p.546-553
5.
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
by Anderson, Daniel G
Nature biotechnology, 2008-05, Vol.26 (5), p.561-569
6.
Does a targeting ligand influence nanoparticle tumor localization or uptake?
by Pirollo, Kathleen F
Trends in biotechnology (Regular ed.), 2008, Vol.26 (10), p.552-558
7.
Vaccine manufacturing: challenges and solutions
by Ulmer, Jeffrey B
Nature biotechnology, 2006-11, Vol.24 (11), p.1377-1383
8.
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
by SHEN, Ben-Quan
Nature biotechnology, 2012, Vol.30 (2), p.184-189
9.
Plants and human health in the twenty-first century
by RASKIN, Ilya
Trends in biotechnology (Regular ed.), 2002, Vol.20 (12), p.522-531
10.
High-throughput process development for biopharmaceutical drug substances
by Bhambure, Rahul
Trends in biotechnology (Regular ed.), 2010, Vol.29 (3), p.127-135
11.
Multifunctional nanoparticles – properties and prospects for their use in human medicine
by Sanvicens, Nuria
Trends in biotechnology (Regular ed.), 2008, Vol.26 (8), p.425-433
12.
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
by Junutula, Jagath R
Nature biotechnology, 2008-08, Vol.26 (8), p.925-932
13.
Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants
by Spök, Armin
Trends in biotechnology (Regular ed.), 2008, Vol.26 (9), p.506-517
14.
A small molecule-kinase interaction map for clinical kinase inhibitors
by Zarrinkar, Patrick P
Nature biotechnology, 2005-03, Vol.23 (3), p.329-336
15.
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
by Reader, Valérie
Nature biotechnology, 2007-09, Vol.25 (9), p.1035-1044
16.
Discovery of transdermal penetration enhancers by high-throughput screening
by Mitragotri, Samir
Nature biotechnology, 2004-02, Vol.22 (2), p.192-197
17.
Nanoparticles for drug delivery to the lungs
by Sung, Jean C
Trends in biotechnology (Regular ed.), 2007, Vol.25 (12), p.563-570
18.
New developments in dry powder pulmonary vaccine delivery
by Sou, Tomás
Trends in biotechnology (Regular ed.), 2010, Vol.29 (4), p.191-198
19.
Comprehensive analysis of kinase inhibitor selectivity
by DAVIS, Mindy I
Nature biotechnology, 2011, Vol.29 (11), p.1046-1051
20.
Recent advances in bone tissue engineering scaffolds
by Bose, Susmita
Trends in biotechnology (Regular ed.), 2012, Vol.30 (10), p.546-554
Filter electronic articles 4.451 Hits
Remove Filters
- Subjects
- Biological And Medical Sciences (4.451)
- Health. Pharmaceutical Industry
- Industrial Applications And Impl... (4.451)
- more ...